Saamya Biotech (India) Limited reported audited standalone earnings results for the quarter and year ended March 31, 2019. For the quarter, the company reported loss of INR 0.055 million against INR 0.1 million reported a year ago. Loss from before exceptional items and tax was INR 0.055 million against INR 0.1 million reported a year ago. For the year, the company reported loss of INR 0.196 million against INR 0.3 million reported a year ago. Loss from before exceptional items and tax was INR 0.196 million against INR 0.3 million reported a year ago.